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We found it entertaining to answer the multiple-choice 
questions concerning enteric infections due to 
Esckerickia coli included in the continuing education 
paper by Drs Garcia and Le Bouguknec [11 but we are 
puzzled about some of the answers. However, first of 
all, we should like to express our surprise that in such 
an educational paper no mention is made of the second 
denomination of Shiga-like toxins (SLT)-which are 
now generally referred to as Shiga toxins (ST)- 
verotoxins or verocytotoxins (VT). The existence of 
hvo parallel nomenclature systems is the basis of 
considerable confusion in the literature concerning this 
subject. No consensus has yet been reached between 
the supporters of the two systenis and it has been 
proposed to use the terms SLT and VT as two alter- 
native and interchangeable names [2]. The arguments 
can be found in the letter proposing substitution of the 
term Shiga toxin for both SLT and VT [3] and in a 
vigorous reaction to this proposition 141. An education 
paper should certainly have mentioned both. Readers 
who are not familiar with the subject should know that 
papers using either one of these names are dealing with 
the same toxins. In particular, two papers using the VT 
~iomenclature have already been published in CMI 
[5,6] but none using the second. The term entero- 
hemorrhagic E. coli (EHEC) has been less practically 
useful because its definition has included clinical, 
epidemiologic and pathogenetic properties difficult to 
confirm in an individual non-0257 isolate (71. How- 
ever, we think that the denomination EHEC can be 
used in the sense that was proposed recently 181: all VT- 
or SLT-producing E.  coli strains are EHEC; the term 
‘typical EHEC’ denotes strains such as 0 1  57:H7 that 
produce VT and attachmentleffacement (A/E) lesions 
and possess the 60-MDa EHEC plasmid, and the term 
‘atypical EHEC’ refers to strains that do not produce 
A/E lesions and/or do not possess the 60-MDa EHEC 
plasmid. 
When reviewing the answers to the self-assessment 
questions provided in the paper, we found four 
inaccuracies. Answer 2a states that non-0157 strains are 
not commonly implicated in cases of SLTEC infection 
in Europe. However, the authors themselves mention 
that other serotypes have been associated with disease. 
Many European papers have underlined the import- 
ance of non-0157 strains in human disease in general 
[6], in hemolytic uremic syndrome (HUS) [5] and in 
outbreaks [9,10]. In a screening of unselected stool 
samples, we found that almost 80% of all VTEC isolates 
were non-0157 [6]. Thus, even if 0 1  57 strains are the 
main cause of HUS, other serotypes also play an 
important role in SLTEC infections in Europe. 
Answer 4b states that almost all SLTEC strains 
produce SLT-11. This is only true for strains of sero- 
group 0157.  We suppose that when the authors state 
in the comment that SLT-I1 toxin is produced by 97% 
of EHEC strains, they mean only strains of serogroup 
0157. However, the definition of EHEC [7]-typical 
EHEC strains in the new nomenclature proposition 
[8]-includes strains of serogroups 0 2 6  and 0 1  11 that 
produce mainly SLT-I, even if some 0 2 6  isolates have 
been shown to produce SLT-I1 15,111. 
Question 5c might discourage the use of sorbitol 
MacConkey agar (SMAC) in the routine clinical 
laboratory while this medium and its improved 
formulas like CT-SMAC are still the best adapted 
means of detection in this context. Indeed, a t  the 
present time, sorbitol-producing 0 157 strains are 
limited to the south of Germany 1121, with a few 
exceptions in neighboring regions such as the Czech 
Republic [ 131. SMAC remains very reliable elsewhere. 
The other techniques cited are still limited to 
specialized laboratories, although enzyme imniuno- 
assays could be used in routine laboratories too, if they 
could be made less expensive. 
Finally, answer 6e suggests that long-term anti- 
biotic therapy may be indicated to obtain clearance of 
the organism. This statement is not supported by the 
authors’ comment. In fact, it seems that the duration 
of fecal carriage is not much affected by antiniicrobial 
therapy [14]. For the prevention of the spread of 
diarrhea in day-care centers, persons with diarrhea 
should be excluded until the diarrhea is resolved, and 
good handwashing should be promoted. I n  o u r  
opinion, the use of antibiotics without proven indica- 
tion should be avoided, to limit the selection ofresistant 
organisms. 
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Response to Drs Pierard and Lauwers 
Clin Microbiol Infect 1998; 4: 415-416 
We should like to thank you for giving us the 
opportunity to respond to the letter from D. Pikrard 
and S. Lauwers concerning the continuing education 
article ‘Enteric infections due to Esckerickia coli’ [ 11. 
First, we should like to make it clear that the aim of our 
paper was to give an overview of E. coli associated with 
enteric infections, with particular emphasis on the 
SLTEC pathotype, which is of growing importance in 
medical microbiology. The purpose was certainly not 
to establish a new nomenclature for this pathotype. In 
addition, our paper was written on the basis of the 
articles published in international journals. 
In our paper no mention was made of the second 
denomination of Shiga-like toxins (SLT): verotoxins or 
verocytotoxins (VT). We agree that this could have 
been done. However, we believe that this denomin- 
ation is not the most suitable, as the term ‘verotoxin’ 
was initially used to designate toxins which were active 
selectively on Vero cells [2]. Since these studies, the 
toxic effects of these proteins have been demonstrated 
on many other cell lines in vitro and in vivo (see 
references in our paper). Therefore, in our view the VT 
denomination is too restrictive. In any case, an 
interested reader, though not familiar with the subject, 
will probably understand that SLT and VT are inter- 
changeable names if he refers to the articles cited in the 
reference section of our paper. We are also surprised by 
the sentence in the letter of Drs Pihard and Lauwers 
concerning the denomination of the Shiga-like toxins, 
in which it is stated that these are ‘now generally 
referred to as Shiga toxins’. No mention of this term 
can be found in the references cited in either their letter 
or our paper. Furthermore, concerning the newly pro- 
posed nomenclature for EHEC, the review by Nataro 
and Kaper [3] was not yet published when we sent our 
paper; thus, no mention could have been made of this 
new definition. In the text, we used the term SLTEC 
for the E. cofi strains producing SLT toxins, irrespective 
of their serotype (0157:H7 or non-O157:H7) or their 
ability to promote attachment/effacement lesions. We 
proposed that ‘SLTEC strains can be classified as EHEC 
when they cause diarrhea or HUS’ (last sentence in 
question 1). Once again, our purpose was not to re- 
define all the terminology on this subject. 
Answer 2a states that ‘non-0157 strains are not 
commonly implicated in cases of SLTEC infections in 
Europe’. We used the term ‘commonly’ and did not 
state that only 0157  isolates are associated with infec- 
tions. This statement is based on two articles published 
in 1996 (references 7 and 8 in our paper) in which it 
was shown that the main cause of HUS in western 
